Efficacy of Low Molecular Weight Heparin in Superficial Vein Thrombosis
Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to establish whether treatment of superficial vein thrombosis (SVT)
with low-molecular-weight heparin in preventive or therapeutic doses prevents disease
progression and thromboembolic events (deep vein thrombosis and pulmonary embolism), whether
efficacy of low-molecular-weight heparin differs with regard to the dosage used (prevention,
treatment), and to recognize groups of patients in which treatment with heparin is most
efficient, as well as to determine factors that influence the efficacy of SVT treatment with
heparin.